Hongmei Zeng
YOU?
Author Swipe
View article: PD-L1 autoregulation promotes the proliferation, migration and invasion of glioblastoma cells via GP130/JAK2/STAT3/IRAK2/IL6 signaling pathway
PD-L1 autoregulation promotes the proliferation, migration and invasion of glioblastoma cells via GP130/JAK2/STAT3/IRAK2/IL6 signaling pathway Open
Glioblastoma (GBM) cells mediate immunosuppressive microenvironment, leading to poor response to programmed death-ligand 1(PD-L1) inhibitor therapy. How PD-L1 in GBM cells confers to GBM immunosuppressive microenvironment remains unclear. …
View article: 885 | GLOBAL BURDEN OF HODGKIN AND NON‐HODGKIN LYMPHOMA: CURRENT TRENDS AND PROJECTED INCIDENCE AND MORTALITY RATES BY 2050
885 | GLOBAL BURDEN OF HODGKIN AND NON‐HODGKIN LYMPHOMA: CURRENT TRENDS AND PROJECTED INCIDENCE AND MORTALITY RATES BY 2050 Open
View article: Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022
Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022 Open
View article: Female Underrepresentation and Adverse Events Reporting Biases in Lung Cancer Clinical Trials: A Systematic Review and Meta-Analysis
Female Underrepresentation and Adverse Events Reporting Biases in Lung Cancer Clinical Trials: A Systematic Review and Meta-Analysis Open
View article: Transition towards cancer mortality predominance over cardiovascular disease mortality in Brazil, 2000–2019: a population-based study
Transition towards cancer mortality predominance over cardiovascular disease mortality in Brazil, 2000–2019: a population-based study Open
National Council for Scientific and Technological Development (CNPq).
View article: Supplementary Table 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Table 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Table 1 shows three major measures of data quality of cancer registries included in this study.
View article: Supplementary Figure 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Figure 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Figure 1 shows the geographic distribution and population coverage of 782 counties included in final analyses, along with the population density of China.
View article: Supplementary Table 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Table 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Table 1 shows three major measures of data quality of cancer registries included in this study.
View article: Supplementary Table 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Table 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Table 2 shows the change in esophageal cancer mortality rates in counties with and without screening programs.
View article: Supplementary Table 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Table 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Table 2 shows the change in esophageal cancer mortality rates in counties with and without screening programs.
View article: Supplementary Figure 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Figure 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Figure 2 was a scatter diagram of the age-standardized esophageal cancer mortality rate in 1973-1975 and the absolute change in mortality rates from 1973–1975 to 2015–2017.
View article: Supplementary Figure 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Figure 2 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Figure 2 was a scatter diagram of the age-standardized esophageal cancer mortality rate in 1973-1975 and the absolute change in mortality rates from 1973–1975 to 2015–2017.
View article: Supplementary Table 3 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Table 3 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Table 3 shows the difference in age-standardized esophageal cancer mortality rates between 90th and 10th percentile counties by province and time period.
View article: Data from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Data from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Background: Geographic variability in esophageal cancer has been reported in China, but data are lacking at the local level. We aimed to investigate changes in disparities in esophageal cancer mortality among Chinese counties and whether c…
View article: Supplementary Table 3 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Table 3 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Table 3 shows the difference in age-standardized esophageal cancer mortality rates between 90th and 10th percentile counties by province and time period.
View article: Supplementary Figure 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017
Supplementary Figure 1 from Changes in geographic variation and socioeconomic inequalities in esophageal cancer mortality in China, 1973-2017 Open
Supplementary Figure 1 shows the geographic distribution and population coverage of 782 counties included in final analyses, along with the population density of China.
View article: Sugar- and Artificially Sweetened Beverages, Proteomic Signatures, and Risk of Liver Outcomes: A Prospective Cohort Study in the UK Biobank
Sugar- and Artificially Sweetened Beverages, Proteomic Signatures, and Risk of Liver Outcomes: A Prospective Cohort Study in the UK Biobank Open
Objectives: To evaluate the association of sweetened beverages and their plasma proteomic signatures with the risk of adverse liver outcomes. Methods: We used data from the UK Biobank with 173,840 participants (40-69 years). Sugar- and art…
View article: Cancer survival statistics in China 2019–2021: a multicenter, population-based study
Cancer survival statistics in China 2019–2021: a multicenter, population-based study Open
Progress in cancer control was evident in China. This highlights the importance of a comprehensive approach to control and prevent cancer.
View article: The meta-analyses on effectiveness and safety of colorectal cancer screening
The meta-analyses on effectiveness and safety of colorectal cancer screening Open
To the Editor: The colorectal cancer (CRC) is the fourth-most common cause of cancer deaths in China that was treated as a public health threat, accounting for approximately 10% of all the cancer-caused mortalities each year.[1] It usually…
View article: Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study
Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study Open
View article: Correlation between abnormal cellular immune and changes of magnetic resonance spectroscopy in patients with Alzheimer’s disease
Correlation between abnormal cellular immune and changes of magnetic resonance spectroscopy in patients with Alzheimer’s disease Open
Not applicable.
View article: Climate factors associated with cancer incidence: An ecological study covering 33 cancers from population-based registries in 37 countries
Climate factors associated with cancer incidence: An ecological study covering 33 cancers from population-based registries in 37 countries Open
Cancer etiology is multifactorial, with climate change and environmental factors such as extreme weather events and ozone layer destruction potentially increasing cancer risk. Investigating climate factors with cancer incidence can provide…
View article: Correlative factors of poor prognosis and abnormal cellular immune function in patients with Alzheimer’s disease
Correlative factors of poor prognosis and abnormal cellular immune function in patients with Alzheimer’s disease Open
BACKGROUND Alzheimer’s disease (AD) is a serious disease causing human dementia and social problems. The quality of life and prognosis of AD patients have attracted much attention. The role of chronic immune inflammation in the pathogenesi…
View article: Cancer incidence and mortality in China, 2022
Cancer incidence and mortality in China, 2022 Open
Cancer remains a major public health concern in China, with a cancer profile that reflects the coexistence of developed and developing regions. Sustained implementation of prevention and control measures has resulted in significant reducti…
View article: Circulating tumor DNA as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis
Circulating tumor DNA as prognostic markers of relapsed breast cancer: a systematic review and meta-analysis Open
In this review, ctDNA measurements at different timepoints are correlated with evaluation indexes at different periods after treatment. The ctDNA can be used as an early potential postoperative prognosis biomarker in breast cancer, and als…
View article: Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050
Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050 Open
Beijing Nova Program (No. Z201100006820069), CAMS Innovation Fund for Medical Sciences (CIFMS, grant No. 2021-I2M-1-023), CAMS Innovation Fund for Medical Sciences (CIFMS, grant No. 2021-I2M-1-010), Talent Incentive Program of Cancer Hospi…
View article: Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN Open
View article: Incidence and Mortality of Cancers in Female Genital Organs — China, 2022
Incidence and Mortality of Cancers in Female Genital Organs — China, 2022 Open
Tailored cancer prevention and control programs specific to each region are necessary to address the growing disease burden.
View article: Cyclooxygenase Succineptide Methyl Ester Combined with Calcium Blockers Inhibits Nlrp3 Inflammasome Activation and Alleviates the Lesions of Alzheimer's Disease Transgenic Mice
Cyclooxygenase Succineptide Methyl Ester Combined with Calcium Blockers Inhibits Nlrp3 Inflammasome Activation and Alleviates the Lesions of Alzheimer's Disease Transgenic Mice Open
View article: Supplementary Table 1 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017
Supplementary Table 1 from Changes in Geographic Variation and Socioeconomic Inequalities in Esophageal Cancer Mortality in China, 1973–2017 Open
Supplementary Table 1 shows three major measures of data quality of cancer registries included in this study.